Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis
出版年份 2015 全文链接
标题
Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis
作者
关键词
GLP1-ra, Fracture, Diabetes mellitus type 2, Cohort study, CPRD
出版物
CALCIFIED TISSUE INTERNATIONAL
Volume 97, Issue 2, Pages 104-112
出版商
Springer Nature
发表日期
2015-04-16
DOI
10.1007/s00223-015-9993-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
- (2014) Johanna H.M. Driessen et al. BONE
- Risk of Lactic Acidosis or Elevated Lactate Concentrations in Metformin Users With Renal Impairment: A Population-Based Cohort Study
- (2014) Willemijn L. Eppenga et al. DIABETES CARE
- Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA
- (2014) D. Prieto-Alhambra et al. OSTEOPOROSIS INTERNATIONAL
- Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
- (2013) Ju-Young Kim et al. LIFE SCIENCES
- Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
- (2013) C. Klop et al. OSTEOPOROSIS INTERNATIONAL
- Risk of fracture in patients with Parkinson’s disease
- (2013) S. Pouwels et al. OSTEOPOROSIS INTERNATIONAL
- Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials (胰高血糖素样肽-1受体激动剂的使用与骨折的关系：一项对随机临床试验的meta分析)
- (2013) Guillaume Mabilleau et al. Journal of Diabetes
- Potential Impact of Benzodiazepine Use on the Rate of Hip Fractures in Five Large European Countries and the United States
- (2012) T. P. Khong et al. CALCIFIED TISSUE INTERNATIONAL
- Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
- (2012) Marloes T. Bazelier et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
- (2011) Ann V. Schwartz JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states
- (2011) Paola Moreno et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
- (2010) M. C. Bunck et al. DIABETES OBESITY & METABOLISM
- Thiazolidinediones and fracture risk in patients with Type 2 diabetes
- (2010) D. J. Betteridge DIABETIC MEDICINE
- Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor
- (2010) Bernardo Nuche-Berenguer et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Validation and validity of diagnoses in the General Practice Research Database: a systematic review
- (2009) Emily Herrett et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States
- (2009) Bernardo Nuche-Berenguer et al. CALCIFIED TISSUE INTERNATIONAL
- Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states
- (2009) Bernardo Nuche-Berenguer et al. REGULATORY PEPTIDES
- The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption
- (2007) Chizumi Yamada et al. ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More